Literature DB >> 3813741

Occult malignant neoplasm in patients with deep venous thrombosis.

R J Goldberg, M Seneff, J M Gore, F A Anderson, H L Greene, H B Wheeler, J E Dalen.   

Abstract

An association between venous thrombosis and cancer was first suggested by Armand Trousseau and subsequently confirmed by multiple postmortem studies. In a previous study, patients with pulmonary embolism, as assessed by pulmonary angiography, were at significantly increased risk of occult cancer with a comparison group of patients without pulmonary embolism. This nonconcurrent prospective epidemiologic study extends these findings by demonstrating a significantly increased risk of occult cancer in patients with deep venous thrombosis (DVT) confirmed by impedance plethysmography as compared with those with suspected DVT in whom the diagnosis was ruled out. Differences in the incidence of malignant neoplasms were greatest within the first two years after the diagnosis of DVT, and patients younger than 50 years with venous thrombosis were at particularly increased risk of occult cancer (relative risk, 19.0). These findings indicate that all patients with DVT or pulmonary embolism should have an appropriate diagnostic workup and careful follow-up, particularly with regard to the risk of occult cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3813741

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Should we look further for cancer in a patient with venous thromboembolism?

Authors:  D E Arterburn; W S Richardson
Journal:  West J Med       Date:  2000-05

Review 2.  Common emergencies in cancer medicine: hematologic and gastrointestinal syndromes.

Authors:  C R Thomas; I K Carter; W T Leslie; F Sutton
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

3.  Tissue procoagulant activity may be important in sustaining metastatic tumour growth.

Authors:  N J Carty; I Taylor; O S Roath; K el-Baruni; J L Francis
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

4.  Recurrent thrombotic occlusions of arteries and veins caused by intravascular metastatic adenocarcinoma.

Authors:  M Levi; C Bronkhorst; L A Noorduyn; J Vreeken
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

Review 5.  Coagulation and cancer: implications for diagnosis and management.

Authors:  M F Loreto ; M De Martinis ; M P Corsi ; M Modesti ; L Ginaldi
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

6.  Deep venous thrombosis and occult malignancy: an epidemiological study.

Authors:  M Nordström; B Lindblad; H Anderson; D Bergqvist; T Kjellström
Journal:  BMJ       Date:  1994-04-02

7.  Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.

Authors:  A Leizorovicz; G Simonneau; H Decousus; J P Boissel
Journal:  BMJ       Date:  1994-07-30

8.  Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Authors:  E Zuckerman; E Toubi; T D Golan; T Rosenvald-Zuckerman; E Sabo; Z Shmuel; D Yeshurun
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study.

Authors:  J T Murchison; L Wylie; D L Stockton
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

10.  Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.

Authors:  Luis Jara-Palomares; Remedios Otero; David Jimenez; Juan Manuel Praena-Fernandez; Carme Font; Conxita Falga; Silvia Soler; David Riesco; Peter Verhamme; Manuel Monreal
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.